# Infectious Disease Testing

Rapid, Accurate Pathogen Detection Powered by Real-Time PCR

LabGen provides advanced infectious disease testing designed to support timely diagnosis, targeted treatment decisions, and improved patient outcomes. As a CLIA-certified high-complexity diagnostic laboratory serving providers nationwide, we deliver precise molecular detection supported by validated instrumentation and strict quality standards.

Our infectious disease division is built on Real-Time PCR technology, ensuring high analytical sensitivity, pathogen-specific detection, and rapid turnaround times across all testing panels.

Why Molecular Infectious Disease Testing Matters

Traditional culture-based or antigen methods may lack the sensitivity or speed required in acute clinical scenarios. Molecular diagnostics using Real-Time PCR enable direct detection of pathogen-specific genetic material with exceptional accuracy.

  • Identifies pathogens at low detection thresholds
  • Reduces false negatives in early-stage infections
  • Supports faster treatment initiation
  • Improves antimicrobial stewardship
  • Enhances clinical confidence in diagnosis

Comprehensive Pathogen Detection

  • Bacterial pathogens
  • Viral infections
  • Respiratory pathogens
  • Gastrointestinal organisms
  • Sexually transmitted infections

Respiratory Infection Panels

  • Influenza viruses
  • Respiratory syncytial virus (RSV)
  • COVID-19
  • Common respiratory bacteria

STI Molecular Testing

  • Routine screening programs
  • Symptomatic diagnosis
  • Follow-up confirmation
  • High-risk patient monitoring

GI Pathogen Detection

  • Bacterial GI pathogens
  • Viral gastrointestinal agents
  • High-sensitivity molecular targets
  • Multi-pathogen panel coverage

Turnaround Time

24–48 Hours

Our molecular laboratory workflow is optimized for efficient specimen processing and rapid reporting without compromising analytical integrity.

  • Early treatment initiation
  • Infection control decision-making
  • Antimicrobial stewardship efforts
  • Reduced patient follow-up delays

Clinical Interpretation & Reporting

  • Pathogen-specific identification
  • Clear positive/negative determinations
  • Quantitative or qualitative interpretation
  • Compliance-ready documentation

Secure electronic reporting integrates seamlessly into provider workflows.

Compliance & Quality Assurance

  • CLIA Certification
  • CAP Proficiency Testing Participation
  • HIPAA Compliance
  • Validated assay performance verification
  • Internal quality control monitoring
  • Secure data transmission systems

Partner With a High-Complexity Molecular Laboratory

LabGen combines advanced molecular technology, reliable 24–48 hour turnaround times, and responsive provider support to deliver trusted infectious disease diagnostic solutions nationwide.

Request Infectious Disease Information
# Infectious Disease Testing – FAQs

Infectious Disease Testing – FAQs

What methodology is used for infectious disease testing?

LabGen uses Real-Time PCR molecular diagnostics for pathogen detection.

What is the turnaround time?

Most infectious disease results are reported within 24–48 hours.

What types of infections can be detected?

Testing includes respiratory pathogens, gastrointestinal organisms, sexually transmitted infections (STIs), and other bacterial and viral targets.

Why is molecular PCR testing preferred?

PCR provides high sensitivity, pathogen-specific detection, and faster results compared to many traditional culture methods.

Can PCR detect early-stage infections?

Yes. Molecular detection identifies pathogen genetic material even at low concentrations.

Does LabGen offer respiratory panels?

Yes. Panels may include influenza, RSV, COVID-19, and other respiratory pathogens.

Does testing support antimicrobial stewardship?

Yes. Rapid identification enables more targeted therapy decisions.

Are results delivered electronically?

Yes. Secure electronic reporting integrates with provider workflows.

Is infectious disease testing performed under high-complexity standards?

Yes. All molecular testing is conducted under high-complexity laboratory requirements.